GAMMA Investing’s Evolent Health EVH Stock Holding History

GAMMA Investing’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.8K	Buy	2,726 +11	+0.4%	+$42	﹤0.01%	3007
2026 Q1	$6.19K	Buy	2,715 +1,400	+106%	+$4.44K	﹤0.01%	3292
2025 Q4	$5.26K	Buy	1,315 +1,207	+1,118%	+$6.71K	﹤0.01%	3253
2025 Q3	$914	Sell	108 -620	-85%	-$6.02K	﹤0.01%	3630
2025 Q2	$8.2K	Sell	728 -270	-27%	-$2.48K	﹤0.01%	2907
2025 Q1	$9.45K	Buy	998 +814	+442%	+$8.22K	﹤0.01%	2770
2024 Q4	$2.07K	Sell	184 -1,401	-88%	-$24.6K	﹤0.01%	3206
2024 Q3	$44.8K	Buy	1,585 +1,556	+5,366%	+$40.1K	﹤0.01%	1567
2024 Q2	$554	Buy	29 +8	+38%	+$204	﹤0.01%	3194
2024 Q1	$689	Hold	21	–	–	﹤0.01%	3028
2023 Q4	$618	Buy	+21	New	+$594	﹤0.01%	2915

Other funds holding EVH

BSP

Benefit Street Partners New York $69.6M AUM

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

TWP

Tempus Wealth Planning Irvine, California $511M AUM 28.39% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

GAMMA Investing's EVH Position: Q2 2026 in Review

GAMMA Investing increased its Evolent Health (EVH) stake by 0.41% in Q2 2026, buying an estimated $42 and bringing the position to 2,726 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3007.

GAMMA Investing first reported a position in EVH in Q4 2023 and has held it in 11 quarters since. The position peaked at $44.8K in Q3 2024. 22 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

GAMMA Investing held 2,726 shares of Evolent Health worth $14.8K as of Q2 2026.
GAMMA Investing bought 11 Evolent Health shares in Q2 2026, an estimated $42.
Evolent Health made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3007 holding.
GAMMA Investing first reported a position in Evolent Health in Q4 2023 and has held it in 11 quarters since.
GAMMA Investing's Evolent Health position peaked at $44.8K in Q3 2024.
22 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.